Merck & Co., Inc.MRKNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank51
3Y CAGR-18.7%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-18.7%/yr
Quarterly compound
Percentile
P51
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.78% |
| Q3 2025 | 6.02% |
| Q2 2025 | 1.89% |
| Q1 2025 | 5.41% |
| Q4 2024 | 4.07% |
| Q3 2024 | 1.81% |
| Q2 2024 | 7.93% |
| Q1 2024 | 8.31% |
| Q4 2023 | -9.49% |
| Q3 2023 | 6.69% |
| Q2 2023 | -17.44% |
| Q1 2023 | 1.76% |
| Q4 2022 | 3.32% |
| Q3 2022 | 2.70% |
| Q2 2022 | 5.65% |
| Q1 2022 | 7.00% |
| Q4 2021 | 6.80% |
| Q3 2021 | 7.54% |
| Q2 2021 | 23.40% |
| Q1 2021 | 6.39% |
| Q4 2020 | -13.22% |
| Q3 2020 | 5.48% |
| Q2 2020 | 5.28% |
| Q1 2020 | 1.75% |
| Q4 2019 | -2.98% |
| Q3 2019 | -2.32% |
| Q2 2019 | 0.88% |
| Q1 2019 | 3.31% |
| Q4 2018 | -15.58% |
| Q3 2018 | 0.09% |
| Q2 2018 | -2.54% |
| Q1 2018 | -1.78% |
| Q4 2017 | -9.20% |
| Q3 2017 | -3.05% |
| Q2 2017 | -0.45% |
| Q1 2017 | -0.24% |
| Q4 2016 | -7.87% |
| Q3 2016 | 1.32% |
| Q2 2016 | -0.90% |
| Q1 2016 | -1.52% |